Reaction

Injection Site Phlebitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 233 reports · 3 co-occurring drugs

As of the last recalculation, Injection Site Phlebitis appears in 233 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FOSAPREPITANT DIMEGLUMINE (PRR 190.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fosaprepitant Dimeglumine26190.0190.4
Bendamustine Hydrochloride1294.394.4
Iron Sucrose987.787.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.